Mia Levy, M.D., Ph.D.

Mia Levy, M.D., Ph.D., a nationally recognized leader in precision oncology and biomedical informatics and a medical oncologist specializing in breast cancer, has served as the Chief Medical Officer of Foundation Medicine since August of 2021. Her tenure at the company has been marked by several impactful partnerships, multiple companion diagnostic approvals for the company’s two U.S. Food and Drug Administration-approved comprehensive genomic profiling tests, and an enhanced focus on promoting equity and access in cancer care. Dr. Levy has led the development of My Cancer Genome, an international knowledge resource for patients and physicians designed to guide treatment decisions based on tumor genetics.